DecodeME
Genetic study on ME/CFS / From Wikipedia, the free encyclopedia
DecodeME is an ongoing genome-wide association study searching for genetic risk factors for ME/CFS. With a planned recruitment of 25,000 patients, it is expected to be the largest such study to date.[1][2] Recruitment closed on 15 November 2023 and results are expected in 2024.
This article is about the ongoing study whether ME/CFS has a genetic risk factor. For the defunct genome testing service, see deCODE genetics.